SPIN is steered by a Scientific Committee that supervises the good development of the Psoriasis International Network. The coordinators of the Scientific Committee represent the committee within the FRT - Fondation Rene Touraine’s Scientific Board.
The mission of the SPIN Committee is to develop the activities of the network, in particular by proposing international collaborative projects, contributing to continuing medical training in the field of skin inflammation and providing support to the development of national and regional networks.
Coordinators of SPIN Scientific Committee
-
-
President-elect
Phyllis SPULSMD, PhD, Consultant Dermatologist at The Academic Medical Centre of the University of Amsterdam, NL
-
Past-president
Luigi NALDIDirector of Centro Studi GISED, Fondazione per la Ricerca Ospedale Maggiore, Bergamo, Italy
-
President FRT Scientific Board
Luis PUIGMD, PhD, Department of Dermatology, Hospital de la Sanat Creu i Sant Pau, Barcelona, Spain
-
Past-President FRT Scientific Board
Thomas LUGERChair of Department of Dermatology, University of Münster, Germany
Members of the committee (by alphabetical order)
Martine BAGOT
Professor and Chairperson, Dermatology Department and INSERM U976, Hôpital Saint Louis, Paris, France
José Manuel CARRASCOSA
Associate Professor Department of Dermatology, Universitary Hospital Germans Trias I Pujol, Badalona, Spain
Romana CEOVIC
MD, PhD, University Department of Dermatovenerology, Zagreb Clinical Hospital and School of Medicine, Zagreb, Croatia
Elke DE JONG
Dermatologist at University Medical Center Nijmegen St Radboud, The Netherlands
Nejib DOSS
Head of the department of Dermatology – Military Hospital of Tunis, Professor Faculty of Medicine Tunis, Tunisia
Emad ELGAMAL
Professor of Dermatology, Venereology and Andrology, Damietta Faculty of Medicine, Al-Azhar University, New Damietta, Egypt
Carsten FLOHR
Professor Carsten Flohr, chair in dermatology and population science, St
John’s Institute of Dermatology, King’s college london
Maria Lorna FREZ
MD, Professor in Dermatology, University of the Philippines College of Medicine – Philippine General Hospital, Philippines
Giampiero GIROLOMONI
Professor of Dermatology and Head of the Dermatology Section in the Department of Medicine at the University of Verona School of Medicine, Verona, Italy
César GONZALEZ
Coordinator Grupo Colombiano de Psoriasis y artritis psoriasica (CoLPsor), Colombia
Alice GOTTLIEB
MD, PhD, Chair of Dermatology, Tufts Medical Centre, Boston, Massachusetts, USA
Christopher EM GRIFFITHS
MD FRCP FMedSci, Professor of Dermatology, The University of Manchester, Manchester Academic Health Science Centre, The Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester, UK
Jan Gutermuth
Professor Jan Gutermuth studied medicine at the Johannes Gutenberg-University Mainz/ Germany and trained in dermatology and allergology at the Humboldt University Berlin (Charité) and Technische University Munich (TUM).
Rolland GYULAI
MD, PhD, Director and chair of the Department of Dermatology, Venerology and Dermatooncology, University of Pécs, Hungary
Kenji KABASHIMA
Pr. Kenji KABASHIMA, Chairman and Head, Department of Dermatology, Kyoto University Graduate School of Medicine, Japan.
Lajos KEMENY
Professor and Chair of the Department of Dermatology and Allergology, University of Szeged, Hungary
Alur S. KUMAR
Professor and Head of Department, Owaisi Hospital Deccan College of Medical Sciences, Hyderabad, India
Richard LANGLEY
MD, FRCPC, Professor of Medicine (Dermatology) and Director of Research, Division of Dermatology, Department of Medicine, Dalhousie University, Canada
Mark LEBWOHL
MD, Sol and Clara Kest Professor and Chairman, Department of Dermatology Icahn School of Medicine at Mount Sinai, New York, NY, USA
Fatimata LY
Head of the Dermatology Department at the Institute of Social Hygiene in Dakar, Professor of Dermatology at the University Cheikh Anta Diop of Dakar, Senegal
Alan MENTER
Chair of research for Dermatology at Baylor Research Institute, Clinical Professor of Dermatology at the University of Texas Southwestern Medical School in Dallas and Professor at Texas A&M Health Science Center, College of Medicine, USA
Ulrich MROWIETZ
MD, Head of Psoriasis-Center, Dept. of Dermatology, Venerology and Allergology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany
Alexander NAST
Department of Dermatology, Venerology and Allergy, Charité – Universitätsmedizin Berlin, Germany
Carle PAUL
Chair of Department of Dermatology, Paul Sabatier University, CHU Larrey, Toulouse, France
Jörg Christoph PRINZ
Univ.-Prof. Dr. med. Univ. Jörg Christoph PRINZ, Clinic for Dermatology and Allergology, Ludwig-Maximilians-University, Munich, Germany
Nélida RAIMONDO
Head of the Department of Dermatology, Air Force Hospital Buenos Aires, Titular Professor of Dermatology at University Maimónides, Buenos Aires, President of the Latin American Society of Psoriasis (SOLAPSO), Argentina
Kristian REICH
Professor of Dermatology at the Georg-August-University Göttingen and at the Dermatologikum Berlin in Germany
Hugo SCHONENBERGER DE OLIVEIRA
MD University Dermatology Clinic, Coimbra University Hospital, Portugal
Lone SKOV
Professor, Consultant, Department of Dermato-Allergology, Gentofte Hospital,
Faculty of Health Sciences, University of Copenhagen, Denmark
Mona STAHLE
Professor of Dermatology and Venereology, Department of Medicine, Solna Karolinska Institute, Stockholm, Sweden
Diamant THAÇI
Professor and Head Comprehensive Center for Inflammation Medicine, University Luebeck, Germany
Jacob THYSSEN
Dr Thyssen is a clinical dermatologist and Professor employed by the
Capital Region and University of Copenhagen in Denmark.
Skaidra VALIUKEVICIENE
Professor and Head of the Department of Skin and Venereal Diseases, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
Peter VAN DE KERKHOF
Chief of the Department of Dermatology, Radboud University Nijmegen Medical Centre, The Netherlands
Christian VESTERGAARD
Aarhus University Hospital | AUH · Department of Dermatology
Richard WARREN
NIHR Clinical Senior Lecturer in Dermatology, Dermatology Centre, University of Manchester, Honorary Consultant Dermatologist Salford Royal NHS Foundation Trust, Manchester, UK
ZHENG Min
Professor and Chairman of the Department of Dermatology at Zhejiang University School of Medicine, China
SPIN Presentation
Recent news
- 2019/06/03 Focus on...
- 2019/05/21 Focus on...
- 2019/04/18 Focus on...
- 2019/04/17 Focus on...
- 2018/07/16 Focus on...
News from the web office
- 2016/10/29
- 2016/05/26
- 2016/02/20
Events
- 2019/04/18 Focus on...
- 2018/02/21
News from medical groups
- 2018/04/18
- 2017/06/21
News from patients associations
- 2017/02/08
- 2016/05/26
Recent publications on Psoriasis and Atopic Dermatitis
on Psoriasis
Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease.
Aliment. Pharmacol. Ther..
2019 Aug , 50, (3):289-294.
Anti-TNFα agents have revolutionised management of chronic inflammatory diseases. Paradoxically, these agents might provoke development of de novo autoimmune diseases.
see on pubmed
Ginsenoside compound K ameliorates imiquimod-induced psoriasis-like dermatitis through inhibiting REG3A/RegIIIγ expression in keratinocytes.
Biochem. Biophys. Res. Commun..
2019 Aug 06, 515, (4):665-671.
Psoriasis is a chronic inflammatory skin disease characterized by keratinocyte hyperproliferation. Ginsenoside compound K (CK), a bioactive metabolite of ginseng, modulates various skin disorders with an impact on keratinocyte biology. However, the effect of Ginsenoside CK in psoriasis has not been explored.
see on pubmed
A vivid cytokines interaction model on psoriasis with the effect of impulse biologic (TNF-α inhibitor) therapy.
J. Theor. Biol..
2019 Aug 07, 474:63-77.
Psoriasis is a chronic skin condition that produces plaques of condensed, scaling skin due to excessively rapid proliferation of keratinocytes. During the disease progression, keratinocyte proliferation is influenced by many immune cells and cytokines. This article deals with a five dimensional deterministic model, which has been derived using quasi-steady-state approximation for describing the dynamics of psoriasis in various cytokines environment. Equilibrium analysis of the system shows (...)
see on pubmed
on Atopic Dermatitis
Rhamnus prinoides (gesho): A source of diverse anti-biofilm activity.
Campbell M et al.
Rhamnus prinoides (gesho): A source of diverse anti-biofilm activity.
J Ethnopharmacol.
2019 Sep 15, 241:111955.
Rhamnus prinoides (gesho) is an evergreen shrub from East Africa traditionally used for the treatment of illnesses including atopic dermatitis, ear, nose and throat infections, pneumonia, arthritis, brucellosis, flu, indigestion and fatigue.
see on pubmed
Gardenia jasminoides extract without crocin improved atopic dermatitis-like skin lesions via suppression of Th2-related cytokines in Dfe-induced NC/Nga mice.
J Ethnopharmacol.
2019 Sep 15, 241:112015.
Atopic dermatitis (AD) is a pruritic, chronic, relapsing inflammatory skin disease. Gardenia jasminoides extract (GJE) has been used as a traditional remedy for the treatment of various inflammatory diseases, including AD. The specific effects of the extract components, which include crocin, geniposidic acid, and gardenoside, on inflammatory responses in AD are not entirely (...)
see on pubmed
Effect of cinnamamides on atopic dermatitis through regulation of IL-4 in CD4 cells.
Choi EJ et al.
Effect of cinnamamides on atopic dermatitis through regulation of IL-4 in CD4 cells.
J Enzyme Inhib Med Chem.
2019 Dec , 34, (1):613-619.
This study aimed to evaluate the effects of cinnamamides on atopic dermatitis (AD) and the mechanisms underlying these effects. To this end, the actions of two cinnamamides, (E)-3-(4-hydroxyphenyl)-N-phenylethyl acrylamide (NCT) and N-trans-coumaroyltyramine (NCPA), were determined on AD by orally administering them to mice. Oral administration of the cinnamamides ameliorated the increase in epidermal and dermal thickness as well as mast cell infiltration. Cinnamamides suppressed serum (...)
see on pubmed
